EXACT Sciences Aktie
WKN: 590273 / ISIN: US30063P1057
|
13.02.2026 23:30:03
|
Exact Sciences Q4 Loss Narrows As Revenues Gain
(RTTNews) - Exact Sciences Corporation (EXAS) on Friday, reported higher revenue for both the fourth quarter and full year ended December 31, 2025, while significantly narrowing its losses.
For the fourth quarter, revenue increased to $878.4 million from $713.4 million in 2024. The company posted a net loss of $86.0 million, sharply reduced from a net loss of $864.6 million in the year-ago quarter. Net loss per share was $0.45, compared with a loss of $4.67 per share in the prior-year period.
For the full year 2025, revenue rose to $3.25 billion from $2.76 billion in 2024. Net loss narrowed to $207.9 million, compared with a net loss of $1.02 billion in the previous year. Net loss per share improved to $1.10 from $5.59 in 2024.
EXAS closed trading on Friday at $103.24 up $0.01 or 0.01 percent on the Nasdaq.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu EXACT Sciences Corp.
Analysen zu EXACT Sciences Corp.
Aktien in diesem Artikel
| EXACT Sciences Corp. | 87,38 | 0,01% |
|
Letzte Top-Ranking Nachrichten
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.